SCHEMBL931012

SCHEMBL931012

OCN(CO)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL38348 1.00
Bromide SCHEMBL28573238 1.00
Hydrochloric Acid SCHEMBL2127639 0.94
Methane SCHEMBL4071167 0.94
Water SCHEMBL8055195 0.94
Fluoride SCHEMBL1813540 0.94
Ethane SCHEMBL21355765 0.89
Methane SCHEMBL8937711 0.89
Boric Acid SCHEMBL3344159 0.85 LMNA (0.36)
Trolamine SCHEMBL8213273 0.78 MAPT (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1963504-A1 METHOD FOR THE EXTRACTION OF BIOMOLECULES FROM FIXED TISSUES Qiagen GmbH (DE) 2008-09-03 EP claimed
WO-2007068764-A1 METHOD FOR THE EXTRACTION OF BIOMOLECULES FROM FIXED TISSUES QIAGEN GMBH (DE) 2007-06-21 WO claimed
US-6897199-B2 Pharmaceutically acceptable salts of phenoxazine and phenothiazine compounds DR. REDDY'S LABORATORIES LTD. (IN) 2005-05-24 US claimed
US-4440675-A PURIFICATION, MULTISTAGE ADSORPTION, ELUTION MELOY LABORATORIES, INC. (US) 1984-04-03 US claimed
US-20230152304-A1 APPLICATION OF COMPOSITION FOR PLATELET DISAGGREGATION, DISAGGREGATION REAGENT AND DISAGGREGATION METHOD SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. (CN) 2023-05-18 US disclosed
EP-3947438-A1 STABILIZED MHC I imusyn GmbH & Co. KG (DE) 2022-02-09 EP disclosed
US-20210252184-A1 WATER-ABSORBING MATERIAL AND USES THEREOF 7905122 CANADA INC. (CA) 2021-08-19 US disclosed
US-11028080-B2 Substituted pyrimidines as LRKK2 inhibitors DENALI THERAPEUTICS INC. (US) 2021-06-08 US disclosed
US-11013823-B2 Water-absorbing material and uses thereof 7905122 CANADA INC. (CA) 2021-05-25 US disclosed
WO-2020201467-A1 STABILIZED MHC I IMUSYN GMBH & CO. KG (DE) 2020-10-08 WO disclosed
US-10591477-B2 Lateral flow device and method of use BIO-RAD LABORATORIES, INC. (US) 2020-03-17 US disclosed
US-20190248875-A1 ZIKA VIRUS VACCINE COMPOSITION AND APPLICATION THEREOF NATIONAL TSING HUA UNIVERSITY (TW) 2019-08-15 US disclosed
US-4643891-A ADMINISTERING AN ELUTED GOLD COMPLEX CONVERTED FROM AN ADSORBED RADIOACTIVE MERCURY COMPOUND MALLINCKRODT DIAGNOSTICA (HOLLAND) B.V. (NL) 1987-02-17 US disclosed
US-4587220-A INCLUDING AN IRON/III/ CHELATE COMPOUND AS A STABILIZER; OCCULT BLOOD MILES LABORATORIES, INC. (US) 1986-05-06 US disclosed
US-4555484-A ALKALI METAL OR AMMONIUM SALT BUFFER SEPARATED FROM REAGENT; STORAGE EASTMAN KODAK COMPANY (US) 1985-11-26 US disclosed
EP-0123115-A2 Ascorbate interference-resistant composition, device and method for the determination of peroxidatively active substances MILES LABORATORIES, INC. (US) 1984-10-31 EP disclosed
US-4470965-A Celiprolol for the treatment of glaucoma USV PHARMACEUTICAL CORPORATION (US) 1984-09-11 US disclosed
US-4414145-A Preparation and use of a 195M-AU-containing liquid BYK-MILLINKCRODT CIL B.V. (NL) 1983-11-08 US disclosed
US-4375515-A CULTURING, UNDER AEROBIC CONDITIONS EXXON RESEARCH AND ENGINEERING CO. (US) 1983-03-01 US disclosed
US-4234435-A Novel carboxylic acid acylating agents, derivatives thereof, concentrate and lubricant compositions containing the same, and processes for their preparation THE LUBRIZOL CORPORATION (US) 1980-11-18 US disclosed